Cite
HARVARD Citation
Campone, M. et al. (n.d.). Health-related quality of life and disease symptoms in postmenopausal women with HR+, HER2− advanced breast cancer treated with everolimus plus exemestane versus exemestane monotherapy. Current medical research and opinion. pp. 1463-1473. [Online].